Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 31;26(1):126-134.
doi: 10.1093/ehjci/jeae245.

Implications of myocardial strain in primary mitral regurgitation-a cardiovascular magnetic resonance study

Simone Romano  1 , Danai Kitkungvan  2   3 , Duc T Nguyen  4 , Carlos El-Tallawi  2 , Edward A Graviss  4 , Afshin Farzaneh-Far  5 , Dipan J Shah  2
Affiliations

Implications of myocardial strain in primary mitral regurgitation-a cardiovascular magnetic resonance study

Simone Romano et al. Eur Heart J Cardiovasc Imaging. .

Abstract

Aims: Chronic primary mitral regurgitation (MR) results in progressive left ventricular (LV) remodelling. Abnormal myocardial deformation (strain) can be present despite preserved ejection fraction (EF). Cardiovascular magnetic resonance (CMR) feature-tracking techniques allow assessment of global longitudinal strain (GLS) from routine cine images. The aim of this study is to evaluate the prognostic value of CMR feature tracking-derived GLS in patients with primary MR.

Methods and results: Consecutive patients undergoing CMR for chronic MR from January 2012 to June 2018 were enrolled. Patients with LVEF <50% were excluded. The composite primary outcome aiming to detect decompensation related to MR comprised (i) referral for mitral surgery owing to symptoms or LV systolic dysfunction or (ii) cardiovascular death. The secondary outcome was all-cause death. A total of 422 patients were followed for a median of 2.7 years, and the primary endpoint was met in 93 patients (34 patients reported symptoms at baseline). At multivariable analysis, GLS≥ -16.6% was associated with primary outcome [hazard ratio (HR) 1.90, P = 0.01]. In moderate MR cohort, patients with GLS≥ -16.6% had worse event-free survival, whereas there was no significant difference in mild or severe MR groups. GLS≥ -16.0% remained associated with all-cause death after adjusting for other covariates including the MR severity (HR 2.24, P = 0.02).

Conclusion: In patients with primary MR with preserved systolic function, GLS was associated with our composite outcomes and all-cause death. GLS may serve as a marker of cardiac dysfunction in the patients with primary MR with preserved systolic function allowing identification of patients likely to decompensate during observation.

Keywords: cardiovascular magnetic resonance imaging; feature tracking; global longitudinal strain; left ventricular function; mitral regurgitation.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None

Figures

Graphical Abstract
Graphical Abstract
Figure 1
Figure 1
A diagram depicting patient selection process.
Figure 2
Figure 2
An example of GLS in patients with severe MR. The top panel demonstrates patients with severe MR with preserved GLS that remained compensated during follow-up period, whereas the bottom panel demonstrates patients on with worse GLS, despite relatively similar regurgitant volume, decompensated requiring mitral surgery.
Figure 3
Figure 3
A prevalence of symptomatic MR at the time of CMR stratified by tertile of GLS.
Figure 4
Figure 4
Incremental value of ECV and GLS in predicting composite outcome (mitral surgery referral and cardiovascular death).
Figure 5
Figure 5
Kaplan–Meier curves for survival free of composite outcome (mitral surgery referral and cardiovascular death).
See this image and copyright information in PMC

References

    1. Apostolidou E, Maslow AD, Poppas A. Primary mitral valve regurgitation: update and review. Glob Cardiol Sci Pract 2017;2017:e201703. - PMC - PubMed
    1. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet 2009;373:1382–94. - PubMed
    1. Lung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW et al. A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on valvular heart disease. Eur Heart J 2003;24:1231–43. - PubMed
    1. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021;143:e35–71. - PubMed
    1. Kalam K, Otahal P, Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart 2014;100:1673–80. - PubMed